New York Daily News: FDA releases coronavirus vaccine guidelines that Trump administration is trying to block, including 2-month safety review


Listen to this article

The U.S. Food and Drug Administration wants coronavirus vaccine developers to follow trial patients for at least two months before seeking emergency approval, according to a newly released set of guidelines that the Trump administration is trying to block.

New York Daily News